TY - JOUR
T1 - Liver Resection for Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava or Right Atrium
T2 - A Large-scale Multicenter Survey Conducted in Japan
AU - Ichida, Akihiko
AU - Kokudo, Takashi
AU - Shimada, Shingo
AU - Hatano, Etsuro
AU - Kubo, Shoji
AU - Kato, Yutaro
AU - Ishikawa, Yoshiya
AU - Mori, Akira
AU - Baba, Hideo
AU - Matsuyama, Yutaka
AU - Endo, Itaru
AU - Yamaue, Hiroki
AU - Yamamoto, Masakazu
AU - Kokudo, Norihiro
AU - Hasegawa, Kiyoshi
N1 - Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/9/1
Y1 - 2023/9/1
N2 - Objective: To clarify the short and long-term postoperative outcomes and surgical indications for patients accompanied by hepatocellular carcinoma with tumor thrombus (TT) in the inferior vena cava (IVC) or right atrium (RA). Background: These patients are known to have an extremely poor prognosis; however, the postoperative outcomes have not been fully verified because of the rarity of this disease. Methods: We contacted 211 specialized centers in Japan and collected data on liver resection for hepatocellular carcinoma with TT in the IVC or RA from centers with experience performing surgery for such patients. The patient characteristics, operative procedures, and surgical outcomes were then analyzed. Results: A total of 119 patients from 23 institutions were enrolled; 49 patients had TT in the IVC below the diaphragm (type I), 42 had TT in the IVC above the diaphragm (type II), and 28 had TT entering the RA (type III). The severity and frequency of postoperative complications did not differ among the 3 groups. There was one surgery-related death in the type III group. The median survival times were 2.47 years in the type I group, 1.77 years in the type II group, and 1.02 years in the type III group. Multivariate analysis identified an indocyanine green retention rate at 15 minutes >15% and ≥3 tumors as prognostic factors affecting survival, whereas the use of cardiopulmonary bypass and ≥3 tumors were risk factors for recurrence. Conclusions: As the postoperative prognosis of patients with type I or type II disease and of patients with no risk factors is relatively good, surgery should be considered for these patient populations.
AB - Objective: To clarify the short and long-term postoperative outcomes and surgical indications for patients accompanied by hepatocellular carcinoma with tumor thrombus (TT) in the inferior vena cava (IVC) or right atrium (RA). Background: These patients are known to have an extremely poor prognosis; however, the postoperative outcomes have not been fully verified because of the rarity of this disease. Methods: We contacted 211 specialized centers in Japan and collected data on liver resection for hepatocellular carcinoma with TT in the IVC or RA from centers with experience performing surgery for such patients. The patient characteristics, operative procedures, and surgical outcomes were then analyzed. Results: A total of 119 patients from 23 institutions were enrolled; 49 patients had TT in the IVC below the diaphragm (type I), 42 had TT in the IVC above the diaphragm (type II), and 28 had TT entering the RA (type III). The severity and frequency of postoperative complications did not differ among the 3 groups. There was one surgery-related death in the type III group. The median survival times were 2.47 years in the type I group, 1.77 years in the type II group, and 1.02 years in the type III group. Multivariate analysis identified an indocyanine green retention rate at 15 minutes >15% and ≥3 tumors as prognostic factors affecting survival, whereas the use of cardiopulmonary bypass and ≥3 tumors were risk factors for recurrence. Conclusions: As the postoperative prognosis of patients with type I or type II disease and of patients with no risk factors is relatively good, surgery should be considered for these patient populations.
KW - cardiopulmonary bypass
KW - hepatocellular carcinoma
KW - inferior vena cava
KW - right atrium
KW - tumor thrombus
UR - http://www.scopus.com/inward/record.url?scp=85167842709&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85167842709&partnerID=8YFLogxK
U2 - 10.1097/SLA.0000000000005789
DO - 10.1097/SLA.0000000000005789
M3 - Article
C2 - 36591790
AN - SCOPUS:85167842709
SN - 0003-4932
VL - 278
SP - E549-E555
JO - Annals of Surgery
JF - Annals of Surgery
IS - 3
ER -